GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
About this study
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.
- Condition
- Acute Lymphoblastic Leukemia, Leukemia, Non-Hodgkin's Lymphoma
- Sponsor
- Goethe University
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Acute Lymphoblastic Leukemia, Leukemia, Non-Hodgkin's Lymphoma
- Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols
- Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols
- Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols
- Age minimum 18 yrs
Where
147 sites, 147 recruiting
Universitätsklinikum Graz
Graz, Austria
LKH-Hochsteiermark Leoben
Leoben, Austria
Ordensklinikum Linz Elisabethinen
Linz, Austria
Universitätsklinikum St. Pölten
Sankt Pölten, Austria
Hanusch-Krankenhaus Wien
Vienna, Austria
Universitätsklinikum Aachen
Aachen, Germany
and 141 more sites on ClinicalTrials.gov
Contact
-
Nicola Gökbuget, Dr. med.
+496963016365 goekbuget@em.uni-frankfurt.de
-
GMALL Study center
Potential match only. Final eligibility is determined by the study team.